Publications
We have significantly contributed to the understanding of health conditions through real-world data analysis. The insights gained from these studies have had a positive impact on clinical practice, leading to more personalised and effective care for patients.
Real-life effectiveness and safety of Salbutamol Steri-neb™ vs. Ventolin Nebules® in preventing exacerbations in patients with COPD: historical cohort study
22 Jan 2018
PLoS One
Authors:
David B. Price, Eran Gefen, Gokul Gopalan, Rosie McDonald, Vicky Thomas, Simon Wan Yau Ming, Emily Davis
Keywords:
COPD, Primary Care
The effect of smoking on exacerbation risk in eosinophilic patients with COPD
19 Dec 2017
European Respiratory Journal
Authors:
Marjan Kerkhof, Elizabeth V. Hillyer, David B. Price
Keywords:
COPD, Oral candidiasis, Chronic obstructive pulmonary disease, Inhaled corticosteroid, Spacer, Dry powder inhaler, Pressurised metered-dose inhaler
Identifying patient attitudinal clusters associated with asthma control: the European REALISE survey
17 Nov 2017
The Journal of Allergy and Clinical Immunology: In Practice
Authors:
Thys van der Molen, Monica Fletcher, and David Price
Keywords:
COPD, Chronic obstructive pulmonary disease, Long-acting bronchodilator, Randomised controlled trial, Real-life research
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
25 Oct 2017
BMJ Open
Authors:
Jaco Voorham, Nicolas Roche, Hicham Benhaddi, Marianka van der Tol, Victoria Carter, Job F.M. van Boven, Leif Bjermer, Marc Miravitlles, David B Price
Keywords:
Adherence, Asthma, CMA, Cohort study, Inhaled corticosteroids, OPCRD, Pharmacoepidemiology
Extrafine versus fine inhaled corticosteroids in relation to asthma control: a systematic review and meta-analysis of observational real-life studies
18 Sept 2017
The Journal of Allergy and Clinical Immunology: In Practice
Authors:
Samatha Sonnappa, Brett McQueen, Dirkje S. Postma, Richard J. Martin, Nicolas Roche, Jonathan Grigg, Theresa Guilbert, Caroline Gouder, Emilio Pizzichini, Akio Niimi, Wanda Phipatanakul, Alison Chisholm, Ronald J. Dandurand, Alan Kaplan, Elliot Israel, Alberto Papi, Willem M.C. van Aalderen, Omar S. Usmani, David B. Price
Keywords:
COPD, prediction, risk factor, model, validation, FEV
Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
14 Sept 2017
Thorax
Authors: